COOPERx Stratégies is a consulting firm specializing in the clinical and pharmacoeconomic evaluation of drugs and health technology.

We have recognized expertise in reimbursement and market access strategies, in particular in the negotiation of product listing and risk-sharing agreements.

We provide highly personalized and results-oriented services. Our clients are true business partners with whom we establish long-term relationships built on mutual trust.

We are proud to offer USOP Rx, the first continuing education platform for healthcare and drug industry professionals regarding optimal drug use and pharmacoeconomics. Visit us at www.usoprx.com

News

January 2018
Great news! Our new division is now launched. USOP Rx is a leading continuing education platform regarding pharmacoeconomic evaluation and optimal drug use for health and drug industry professionals.
August 2017
We are proud to have participated, in March 2017, in a Harvard University training program to increase our negotiation skills and to broaden our range of strategies in order to optimize our service offering regarding the negotiation of drug listing agreements. Contact us for further details!
June 2017
We attended the “Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada” symposium by the Canadian Association for Healthcare Reimbursement (CAHSP/CAHR)
April 2017
Participation in the CADTH Symposium in Ottawa